United Kingdom· GB-APID-195811000001105
Novasource GI Control liquid
A medicinal product, registered in United Kingdom by Nestle Health Science.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Manufacturer
- Nestle Health Science
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin7613031648696
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1978ca17-c343-4805-9e11-3e304bb140e2 GET /v1/drugs/1978ca17-c343-4805-9e11-3e304bb140e2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "195811000001105",
"desc": "Novasource GI Control liquid (Nestle Health Science)",
"form": "Gastroenteral liquid",
"vpid": "3548511000001105",
"source": "dmd",
"vtm_id": null,
"strength": null,
"substance": null,
"ingredient": null,
"supplier_code": "2884201000001102"
}See everything about Novasource.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.